Researcher.Life Logo

Rheumatology : Impact Factor & More

eISSN: 1462-0332pISSN: 1462-0324

Key Metrics

CiteScore
8.5
H-Index
192
Impact Factor
5 - 10
Scite Index
0.86 5-Year SI
SJR
Q1Rheumatology
SNIP
1.82
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Rheumatology

Rheumatology Journal Specifications

Overview
Publisher OXFORD UNIV PRESS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Rheumatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Rheumatology

Cross-national biologic treatment guidelines for familial Mediterranean fever: a comparative analysis.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Comment on: Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort study.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Risk of systemic lupus erythematosus elevated years after testing positive for antinuclear antibodies: national cohort study in Denmark.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Benefits of adjunct plasma exchange in idiopathic inflammatory myopathy with anti-signal recognition particle antibodies:a real-world study.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
High-sensitivity serum interferon-α and interferon-γ as immunometabolic mediators of metabolic syndrome in systemic lupus erythematosus.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Belimumab use in pediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Cross-national biologic treatment guidelines for familial Mediterranean fever: a comparative analysis.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Comment on: Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort study.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Risk of systemic lupus erythematosus elevated years after testing positive for antinuclear antibodies: national cohort study in Denmark.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Benefits of adjunct plasma exchange in idiopathic inflammatory myopathy with anti-signal recognition particle antibodies:a real-world study.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
High-sensitivity serum interferon-α and interferon-γ as immunometabolic mediators of metabolic syndrome in systemic lupus erythematosus.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)
Belimumab use in pediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study.
  • 26 Apr 2026
  • Rheumatology (Oxford, England)

FAQs on Rheumatology